Stephen Hahn, FDA commissioner (AP Images)

FDA touts ad­vanced man­u­fac­tur­ing to ad­dress Covid-19 short­falls

Ad­vanced man­u­fac­tur­ing tech­niques can be em­ployed to help ad­dress some of the man­u­fac­tur­ing and sup­ply chain prob­lems the US has seen dur­ing the Covid-19 pan­dem­ic, Stephen Hahn, FDA com­mis­sion­er, and Anand Shah, FDA deputy com­mis­sion­er for med­ical and sci­en­tif­ic af­fairs, wrote in a blog post on the FDA web­site.

“The po­ten­tial pub­lic health val­ue of ad­vanced man­u­fac­tur­ing is even greater in the con­text of the on­go­ing COVID-19 pan­dem­ic, which has high­light­ed the strain on sup­ply chains and the need for adap­tive man­u­fac­tur­ing sys­tems to ac­cel­er­ate the pro­duc­tion of med­ical coun­ter­mea­sures,” Hahn and Shah wrote. “The FDA has es­tab­lished a strong reg­u­la­to­ry foun­da­tion to sup­port the up­take of ad­vanced man­u­fac­tur­ing, and COVID-19 pro­vides the unique im­pe­tus to spur fur­ther ad­vance­ment of med­ical man­u­fac­tur­ing.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.